News

TriMas Corporation TRS reported fourth-quarter 2025 adjusted earnings per share (EPS) of 40 cents, missing the Zacks Consensus Estimate of 41 cents. The bottom line decreased 7% from the prior-year

Main Street Capital Corporation’s MAIN fourth-quarter 2025 distributable net investment income of $1.09 per share surpassed the Zacks Consensus Estimate of $1.05. The reported figure compares

Both Skillsoft SKIL and Duolingo DUOL navigate through the digital education space, providing online learning platforms that monetize via subscriptions and enterprise solutions. Long-term shifts

Shares of Hamilton Beach Brands Holding Company HBB have outperformed the broader market, following the release of its fourth-quarter 2025 results. The stock has climbed 6.7% since reporting

Restaurant operators continue to operate in a competitive environment marked by shifting consumer demand, cost pressures and the need to balance growth with operational discipline. In this

Willdan Group, Inc. WLDN reported fourth-quarter fiscal 2025 (ended Jan. 2, 2026) results, with adjusted earnings and revenues beating the Zacks Consensus Estimate. On the other hand, the top and

Serve Robotics SERV appears to be transitioning from a pilot-stage robotics company into a scaled autonomy platform — and 2026 could mark the inflection point.Scale is the first layer of its moat

Increasing aircraft deliveries worldwide, fleet expansion by airlines and rising demand for maintenance, repair and overhaul (MRO) services are fueling growth across the aviation services sector

At its 2026 shareholder update, The Carlyle Group Inc. CG highlighted that the company’s disciplined execution is driving a tangible, record-breaking performance. Despite navigating a challenging

OPKO Health, Inc. OPK delivered a loss per share of 4 cents in the fourth quarter of 2025, against an earnings per share of a cent in the prior-year quarter. Earnings beat the Zacks Consensus

Range Resources Corporation RRC reported fourth-quarter 2025 adjusted earnings of 82 cents per share, which beat the Zacks Consensus Estimate of 68 cents. The bottom line also improved from the

The Estee Lauder Companies’ EL Skin Care remained a key bright spot in second-quarter fiscal 2026, supported by stronger retail trends in select markets. Performance in Mainland China and continued

Rocket Pharmaceuticals RCKT incurred a loss of 38 cents per share in the fourth quarter of 2025, which was narrower than the Zacks Consensus Estimate of a loss of 42 cents. In the year-ago quarter

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Wolverine World Wide, Inc. WWW reported impressive fourth-quarter 2025 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. Also, revenues and earnings grew year over

Solventum SOLV reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.57, which beat the Zacks Consensus Estimate of $1.50 by 4.7%. The bottom line improved 11.3% year over year.

GAAP

D-Wave Quantum Inc. QBTS reported a fourth-quarter 2025 net loss of 12 cents per share compared with the Zacks Consensus Estimate of a loss of 5 cents. However, the figure compares favorably with

Universal Health Services, Inc. UHS reported fourth-quarter 2025 adjusted earnings per share (EPS) of $5.88, which missed the Zacks Consensus Estimate by 0.6%. The bottom line soared 19.5% year over

Clover Health Investments, Corp. CLOV delivered an adjusted fourth-quarter 2025 loss per share of 5 cents, against the year-ago period’s adjusted earnings per share (EPS) of 2 cents. The bottom line